The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / K••• P••••••••• a•• A•••••• L•••••••••

••• Locked

Platform acquisitionannouncedannounced Jun 5, 2019Fact
What happened
Target
K••• P••••••••• a•• A•••••• L•••••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / laborator, pharma
Target location
unknown
Seller kind
Corporate parent
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
15 named
Buy side
Sell side
Advisory side
  • D•• P••••Buy-side adviserconfirmed
    “••• Locked”
  • C•••••••• G•••••• C••••Buy-side adviserconfirmed
    “••• Locked”
  • H••••••• L••••Financial adviserconfirmed
    “••• Locked”
  • G•••••• S•••• I•••••••••Financial adviserconfirmed
    “••• Locked”
Evidence
“••• Locked”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 18, 2026
••• Locked | Private Equity Intelligence | DFX